应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TMDX TransMedics Group Inc.
盘前交易 07-01 08:19:18 EDT
150.62
+2.80
+1.89%
盘前
150.75
+0.13
+0.09%
08:00 EDT
最高
152.32
最低
146.25
成交量
135.76万
今开
148.05
昨收
147.82
日振幅
4.11%
总市值
49.61亿
流通市值
48.00亿
总股本
3,294万
成交额
2.03亿
换手率
4.26%
流通股本
3,187万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-TransMedics 因上调 24 财年业绩预期和强劲的第一季度业绩而上涨
Reuters · 05-01
BUZZ-TransMedics 因上调 24 财年业绩预期和强劲的第一季度业绩而上涨
Transmedics Group Inc 报告截至三月份的季度业绩 - 收益摘要
Reuters · 05-01
Transmedics Group Inc 报告截至三月份的季度业绩 - 收益摘要
Transmedics Group Inc 预计每股亏损 5 美分 - 财报前瞻
Reuters · 04-27
Transmedics Group Inc 预计每股亏损 5 美分 - 财报前瞻
美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司
Reuters · 02-27
美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司
Transmedics Group Inc 报告截至 12 月的季度业绩 - 收益摘要
Reuters · 02-27
Transmedics Group Inc 报告截至 12 月的季度业绩 - 收益摘要
Transmedics Group Inc 预计每股亏损3美分 - 财报前瞻
Reuters · 02-24
Transmedics Group Inc 预计每股亏损3美分 - 财报前瞻
加载更多
公司概况
公司名称:
TransMedics Group Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
TransMedics Group, Inc.于1998年8月注册。该公司是一家商业阶段医疗技术公司,为多个疾病状态的终末期器官衰竭患者提供器官移植治疗。该公司开发了接触网,以取代几十年来的护理标准。该公司创新的接触网技术复制了人体外器官自然生活和功能环境的许多方面。OCS代表了一种方式的转变,将器官移植保存从静态状态转变为动态环境,从而实现新的功能,包括器官优化和评估。
发行价格:
--
{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group Inc.","latestPrice":150.62,"timestamp":1719604800000,"preClose":147.82,"halted":0,"volume":1357631,"hourTrading":{"tag":"盘前","latestPrice":150.75,"preClose":150.62,"latestTime":"08:00 EDT","volume":82,"amount":12380.7003,"timestamp":1719835204082},"delay":0,"floatShares":31871115,"shares":32937296,"eps":-0.315834,"marketStatus":"盘前交易","marketStatusCode":1,"change":2.8,"latestTime":"07-01 08:19:18 EDT","open":148.05,"high":152.32,"low":146.25,"amount":203264513.32,"amplitude":0.041063,"askPrice":151.9,"askSize":30,"bidPrice":150.7,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-0.315834,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1719840600000},"adr":0,"listingDate":1556769600000,"adjPreClose":150.62,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":150.75,"preClose":150.62,"latestTime":"08:00 EDT","volume":82,"amount":12380.7003,"timestamp":1719835204082},"postHourTrading":{"tag":"盘后","latestPrice":150.5,"preClose":150.62,"latestTime":"19:16 EDT","volume":48748,"amount":7341418.12066,"timestamp":1719616589509},"volumeRatio":2.042573198277595,"impliedVol":0.6679,"impliedVolPercentile":0.58},"requestUrl":"/m/hq/s/TMDX","defaultTab":"news","newsList":[{"id":"2432528919","title":"BUZZ-TransMedics 因上调 24 财年业绩预期和强劲的第一季度业绩而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2432528919","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432528919?lang=zh_cn&edition=full","pubTime":"2024-05-01 17:56","pubTimestamp":1714557413,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月1日 - ** 医疗设备制造商TransMedics 股价盘前上涨13.6%至106.91美元** 该公司预计 24 财年营收在 3.9 亿至 4 亿美元之间,高于之前预测的 3.6 亿至 3.7 亿美元。** 第一季度收入 9,690 万美元,超过华尔街预估的 8,380 万美元 - LSEG 数据 ** 公司季度净利润为1220万美元,而2023年第一季度净亏损为260万美元** 七家券商中有六家将该股评为 \"买入 \"或更高评级,一家为 \"持有\";评级中值为117美元** 截至本周二收盘,该公司股价已累计上涨 19.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","BUZZ","TMDX","BK4585"],"gpt_icon":0},{"id":"2432556480","title":"Transmedics Group Inc 报告截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432556480","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432556480?lang=zh_cn&edition=full","pubTime":"2024-05-01 07:23","pubTimestamp":1714519405,"startTime":"0","endTime":"0","summary":" * Transmedics Group Inc 报告了截至3月底的季度调整后每股收益35美分,高于去年同期的每股收益-8美分。七位分析师对该季度的平均预期是每股亏损 5 美分。华尔街预期为每股-33美分至11美分。* Transmedics Group Inc公布的本季度每股收益为35美分。* 公司报告的季度净收入为1220万美元。* Transmedics Group Inc的股价本季度上涨了31.5%,今年迄今为止上涨了23.2%。华尔街对 Transmedics Group Inc 的 12 个月目标价中位数为 100.00 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","BK4585","TMDX"],"gpt_icon":0},{"id":"2430732362","title":"Transmedics Group Inc 预计每股亏损 5 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2430732362","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430732362?lang=zh_cn&edition=full","pubTime":"2024-04-27 05:44","pubTimestamp":1714167851,"startTime":"0","endTime":"0","summary":" * Transmedics Group Inc 将于4月30日公布截至2024年3月31日的财报,预计该公司的季度收入将有所增长。* 根据6位分析师基于LSEG数据得出的平均预期,这家总部位于马萨诸塞州安多弗的公司的营收预计将从去年同期的4155万美元增长101.6%,达到8377.8万美元。* LSEG 分析师对 Transmedics Group Inc 的平均预期为每股亏损 5 美分。* 华尔街对 Transmedics Group Inc 的 12 个月目标价中位数为 100.00 美元,高于其 92.08 美元的最新收盘价。4月26日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":0},{"id":"2414849832","title":"美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2414849832","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414849832?lang=zh_cn&edition=full","pubTime":"2024-02-27 15:31","pubTimestamp":1709019083,"startTime":"0","endTime":"0","summary":" 路透社2月27日 - 华尔街证券分析师周二调整了对 Agiliti、多米诺比萨和 Krystal Biotech 等几家美国上市公司的评级和目标价。公司要闻 * Agiliti公司 :杰富瑞将其评级从 \"买入 \"下调至 \"持有 * 多米诺比萨 :杰富瑞将目标价从400美元上调至455美元 * Krystal Biotech Inc :Evercore ISI将其股票从战术跑赢大盘名单中除名 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VMI","OPAD","WDAY","NDSN","AFRM","BK4534","GH","FATE","MSTR","DVA","WMT","TREX","CDE","CARG","KRYS","INVH","RARE","LU2430703178.SGD","LU2430703251.USD","BK4535","DPZ","LU2264538146.SGD","QTWO","LU1280957306.USD","SG9999001176.SGD","SG9999014880.SGD","EFX","LU1804176565.USD","PCG","FIS","STAA","ITRI","LU2491049909.HKD","UPST","BECN","FRPT","WRB","WYNN","PUBM","LU2491050071.SGD","LLY","EVER","COGT","AGTI","TMDX","BK4533","VCYT","DKNG","SFM","ANRO"],"gpt_icon":0},{"id":"2414186672","title":"Transmedics Group Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2414186672","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414186672?lang=zh_cn&edition=full","pubTime":"2024-02-27 06:42","pubTimestamp":1708987369,"startTime":"0","endTime":"0","summary":" * Transmedics Group Inc 报告了截至12月底的季度调整后每股收益12美分,高于去年同期的每股收益-21美分。六位分析师对该季度的平均预期是每股亏损 3 美分。华尔街预期为每股-8美分至8美分。* 营收同比增长 158.7%,达到 8117 万美元;分析师预期为 6851 万美元。* Transmedics Group Inc公布的本季度每股收益为12美分。* 公司报告的季度净收入为 403 万美元。* 本季度,Transmedics Group Inc 的股价上涨了 5.3%。* 华尔街对 Transmedics Group Inc 的 12 个月目标价中位数为 92.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4082","TMDX"],"gpt_icon":0},{"id":"2413741157","title":"Transmedics Group Inc 预计每股亏损3美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413741157","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413741157?lang=zh_cn&edition=full","pubTime":"2024-02-24 09:20","pubTimestamp":1708737612,"startTime":"0","endTime":"0","summary":" * Transmedics Group Inc 将于2月26日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,5位分析师的平均预期显示,这家总部位于马萨诸塞州安多弗的公司的营收预计将从去年同期的3138万美元增长118.3%,达到6850.7万美元。* LSEG 分析师对 Transmedics Group Inc 的平均预期是每股亏损 3 美分。* 华尔街对 Transmedics Group Inc 的 12 个月目标价中位数为 92.00 美元,高于上一交易日 83.14 美元的收盘价。2月24日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.0833},{"period":"1month","weight":0.0585},{"period":"3month","weight":1.0371},{"period":"6month","weight":0.9083},{"period":"1year","weight":0.7806},{"period":"ytd","weight":0.9083}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TransMedics Group, Inc.于1998年8月注册。该公司是一家商业阶段医疗技术公司,为多个疾病状态的终末期器官衰竭患者提供器官移植治疗。该公司开发了接触网,以取代几十年来的护理标准。该公司创新的接触网技术复制了人体外器官自然生活和功能环境的许多方面。OCS代表了一种方式的转变,将器官移植保存从静态状态转变为动态环境,从而实现新的功能,包括器官优化和评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.000366},{"month":2,"riseRate":0.6,"avgChangeRate":0.17221},{"month":3,"riseRate":0.4,"avgChangeRate":0.046405},{"month":4,"riseRate":0.6,"avgChangeRate":0.057015},{"month":5,"riseRate":0.4,"avgChangeRate":0.07653},{"month":6,"riseRate":1,"avgChangeRate":0.175838},{"month":7,"riseRate":0.6,"avgChangeRate":0.015883},{"month":8,"riseRate":0.6,"avgChangeRate":0.027049},{"month":9,"riseRate":0.2,"avgChangeRate":-0.1173},{"month":10,"riseRate":0.2,"avgChangeRate":-0.141298},{"month":11,"riseRate":0.8,"avgChangeRate":0.278435},{"month":12,"riseRate":0.6,"avgChangeRate":0.052396}],"exchange":"NASDAQ","name":"TransMedics Group Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group Inc.(TMDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TransMedics Group Inc.(TMDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TransMedics Group Inc.,TMDX,TransMedics Group Inc.股票,TransMedics Group Inc.股票老虎,TransMedics Group Inc.股票老虎国际,TransMedics Group Inc.行情,TransMedics Group Inc.股票行情,TransMedics Group Inc.股价,TransMedics Group Inc.股市,TransMedics Group Inc.股票价格,TransMedics Group Inc.股票交易,TransMedics Group Inc.股票购买,TransMedics Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group Inc.(TMDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TransMedics Group Inc.(TMDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}